During FY21, PAT has more than doubled (110% up from FY20) on the back of higher specialty sales, better-operating margins, and uptick performance by subsidiaries. FY21 ROCE and ROE stands at 22% and 30% respectively while EPS increased by 115% (vs PY) to Rs 127 per share. Net debt at Rs 438-crores is close to one time to EBITDA.
Results for Q4 are even stronger than the first three quarters of the year driven by continued specialty films growth in Indian as well as overseas operations.
Pankaj Poddar, CEO, Cosmo Films, said, “Cosmo Films is a name to reckon globally for newer, innovative solutions. The specialty films sales have grown yoy in the last three years and growth rate in FY21 surpassed 20% despite the base becoming larger each passing year reaffirming the company’s growth strategy through continuous investment in R&D, sales and marketing, employee practices, quality and customer satisfaction. The significant share of specialty films in the overall sales has made a strong foundation for Cosmo and will help the company do well even in the tougher times.”
On expansion front, construction of a specialised BOPET line has started and is running as per plan even with significant Covid-related challenges. The internal consumptions for Materbatch is growing and the external sales will start soon. The company has successfully completed development of several textile chemical products, each with specific USPs.
“These are currently under trials with textile manufacturers and processors. Commercial launch would follow in H1FY22. Pet care pilot launch will start in Q2 FY22 under the brand name Zigly, and will provide unique value proposition to pet parents across different channels,” he added.